Platelets protect lung from injury induced by systemic inflammatory response

Area of Science:

• Cardiovascular Biology
• Pulmonary Medicine
• Hematology

Background:

• Systemic inflammation can cause severe lung injury.
• Extracorporeal circulation (ECC) can induce systemic inflammatory responses.
• Investigating methods to mitigate ECC-induced lung injury is crucial.

Purpose of the Study:

• To determine if platelets can attenuate lung injury caused by ECC-induced systemic inflammation in mice.
• To explore the mechanisms by which platelets might protect the lungs.

Main Methods:

• Mice underwent 30 minutes of ECC.
• Mice were treated with saline, platelets, Tirofiban (a GPIIb/IIIa inhibitor), or platelets plus Tirofiban.
• Lung injury and inflammatory markers were assessed 60 minutes post-ECC.

Main Results:

• ECC induced systemic inflammation and pulmonary dysfunction.
• Platelet transfusion significantly reduced lung injury and improved lung function.
• Platelet transfusion increased circulating platelet-leukocyte aggregates and lung platelet accumulation.
• Platelets increased transforming growth factor-β and decreased tumor necrosis factor-α and neutrophil elastase.
• Tirofiban abolished the protective effects of platelets.

Conclusions:

• Platelets can protect the lungs from injury induced by systemic inflammation during ECC.
• Platelet-mediated lung protection involves modulation of inflammatory cytokines and neutrophil activity.
• The protective effects of platelets are dependent on GPIIb/IIIa receptor function.